Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period.

Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Abstract Text:

    The value of prophylactic anti-lymphocyte globulin (ALG) treatment after transplantation was examined in a prospectively randomised study. The control group was treated with azathioprine and steroids only. In a third group prophylactic ALG combined with azathioprine and steroids was given for 8.7 +/- 2.25 days after transplantation and was then replaced by cyclosporine and steroids. Renal graft survival rates could be improved if the conventional immunosuppression was accompanied by ALG prophylaxis. However, additional cyclosporine treatment proved to be desirable since in this way the number of early acute rejection episodes could be further reduced.

    Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Publishing Authors By Initials

    For similar therapeutics: renal replacement therapy: kidney transplantation research abstracts see: therapeutics: renal replacement therapy: kidney transplantation research

    PUBMED ID PMID:

    MEDLINE DATE:

    Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Journal Published:

    PUBLICATION TYPE: Randomized Controlled Trial

    Journal: Proceedings of the European Dialysis and Transplan

    VOLUME: 21

    Page Numbers: 987-91

    Journal Abbreviation:

    ISSN: 0308-9401

    DAY: 26

    MONTH: 02

    YEAR: 1985

    Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 8503947

    Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Keywords Mesh Terms:

    KEYWORDS: Kidney Transplantation

    MESH TERMS: therapeutic use

    Chemical & Substance for Abstract: Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period. Information

    Substance Name: Immunosuppressive Agents

    Registry Number: 0

    Grant and Affiliation Information for Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period.

    AFFILIATION:

    Country: ENGLAND

    ENGLAND Research PublicationENGLAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Proc Eur Dial Transplant Assoc

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Improvement in cyclosporine handling by anti-lymphocyte globulin in the early post-operative period Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News